Jeff Hammerbacher — From data science to biomedicine

Jeff Hammerbacher — From data science to biom...

Up next

The $64M Bet on an AI That Has to Be Right | Carina Hong, CEO of Axiom

Formal verification already consumes years of human effort.In this episode, Lukas Biewald talks with Carina Hong, Founder & CEO of Axiom, about why verification is becoming the real bottleneck in high stakes AI systems.They discuss how Axiom uses AI to take on the tedious checkin ...  Show more

What a $42B Software Co. Really Spends on AI Tools

“I don't worry about being replaced by AI. I worry about being replaced by someone who's really good at using AI.”Atlassian has 10,000+ engineers currently split-testing the world’s top AI coding tools, from GitHub Copilot and Cursor to Claude Code. In this episode, Co-Founder & ...  Show more

Recommended Episodes

1955: Quanterix (NASDAQ: QTRX) Biomarker Detection Technology
Tech Talks Daily

Kevin Hrusovsky, CEO of Quanterix and the Powering Precision Health Summit founder, joins me on the Tech Talks Daily Podcast. Kevin has more than 25 years of experience leading life sciences and biotechnology companies and believes that accelerating precision medicine is the k ...

  Show more

Discovery, Translation, and the State of Bio Today
Raising Health

On this episode, we are taking a pulse-check on the state of the intersection between biology, healthcare, and technology with two scientists that sit at another intersection, that of academia and industry: Alexander Marson and Patrick Hsu, who are professors at UC San Francis ...

  Show more

What exactly is "data science" these days? (Practical AI #80)
Changelog Master Feed

Matt Brems from General Assembly joins us to explain what "data science" actually means these days and how that has changed over time. He also gives us some insight into how people are going about data science education, how AI fits into the data science workflow, and how to diff ...  Show more